These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11564944)

  • 1. A rare case of hepatic carcinoid.
    Tagliabue L; Tarolo GL; Bestetti A; Di Leo C; Del Sole A
    Clin Nucl Med; 2001 Oct; 26(10):893. PubMed ID: 11564944
    [No Abstract]   [Full Text] [Related]  

  • 2. In-111 labeled octreotide imaging of a primary carcinoid lesion undetected by conventional imaging studies in a patient with "chronic pancreatitis".
    Kummar S; Kim SL; Halkar RK; Galt JR
    Clin Nucl Med; 1996 Aug; 21(8):634-7. PubMed ID: 8853917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of octreotide in the regression of a metastatic carcinoid tumour despite negative imaging with In-111-pentetreotide (Octreoscan).
    Hillman N; Herranz L; Alvarez C; Martínez Olmos MA; Márco A; Gómez-Pan A
    Exp Clin Endocrinol Diabetes; 1998; 106(3):226-30. PubMed ID: 9710364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoactive intestinal peptide and somatostatin receptor scintigraphy for differential diagnosis of hepatic carcinoid metastasis.
    Kurtaran A; Raderer M; Müller C; Prokesch R; Kaserer K; Eibenberger K; Koperna K; Niederle B; Virgolini I
    J Nucl Med; 1997 Jun; 38(6):880-1. PubMed ID: 9189133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gallbladder visualization at twenty-four hours with octreotide scintigraphy. Potential false-positive finding.
    Kipper MS; Krohn LD
    Clin Nucl Med; 1997 Apr; 22(4):253-4. PubMed ID: 9099484
    [No Abstract]   [Full Text] [Related]  

  • 6. Hilar bronchial carcinoid tumor: increased peritumoral vascular expression of somatostatin-2 receptor on an octreotide study?
    Koh E; Patrikeos A; Steens R; Robins P
    Clin Nucl Med; 2001 Oct; 26(10):870-1. PubMed ID: 11564931
    [No Abstract]   [Full Text] [Related]  

  • 7. 111In-octreotide scintigraphy in endocrine tumors. Preliminary data.
    Cremonini N; Furno A; Sforza A; Chiarini V; Graziano E; Zampa G; Turba E
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):116-20. PubMed ID: 9002767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case report: Radiolabelled octreotide scanning as a guide to the management of an occult carcinoid tumour.
    Mahadeva R; Wraight EP; Shneerson JM
    Clin Radiol; 1998 Sep; 53(9):705-6. PubMed ID: 9766727
    [No Abstract]   [Full Text] [Related]  

  • 9. [Primary and follow-up studies of patients with carcinoid metastases using indium 111 octreotide--rational use of Sandostatin].
    Lipp RW; Hammer HF; Passath A; Dobnig H; Ramschak-Schwarzer S; Stiegler C; Leb G; Krejs GJ
    Acta Med Austriaca; 1993; 20(1-2):42-4. PubMed ID: 8475679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary renal carcinoid tumor with liver metastases detected with somatostatin receptor imaging.
    Mufarrij P; Varkarakis IM; Studeman KD; Jarrett TW
    Urology; 2005 May; 65(5):1002. PubMed ID: 15882749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Octreotide scanning for carcinoid tumours.
    Critchley M
    Postgrad Med J; 1997 Jul; 73(861):399-402. PubMed ID: 9338023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-111 octreotide scan in a case of a neuroendocrine tumor of unknown origin.
    Fuster D; Navasa M; Pons F; Vidal-Sicart S; Mateos JJ; Lomeña F; Rodes J; Herranz R
    Clin Nucl Med; 1999 Dec; 24(12):955-8. PubMed ID: 10595476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of a carcinoid tumor by the radionuclide method.
    Crasset V; Delcourt E; Dekoninck W
    Clin Nucl Med; 1994 Oct; 19(10):919. PubMed ID: 7805335
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of somatostatin analog for localization and treatment of ACTH secreting bronchial carcinoid tumor.
    Christin-Maitre S; Chabbert-Buffet N; Mure A; Boukhris R; Bouchard P
    Chest; 1996 Mar; 109(3):845-6. PubMed ID: 8617102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bone scintigraphy and scintigraphy with (111)In-octreotide in the diagnosis of bone metastasis of bronchial carcinoid tumor].
    Pérez Angel F; Sánchez Catalicio J; Mohamed Salem L; Castellón Sánchez MI; Navarro Fernández JL; Claver Valderas MA
    Rev Esp Med Nucl; 2010; 29(1):38-9. PubMed ID: 19837486
    [No Abstract]   [Full Text] [Related]  

  • 16. Primary ovarian carcinoid: value of octreotide scintigraphy for diagnosis and correlation with other cross-sectional imaging modalities and pathology.
    Trapanotto V; Hamper UM; Gordon A; Krasner AS; Civelek AC
    J Ultrasound Med; 1997 Jul; 16(7):505-8. PubMed ID: 9315203
    [No Abstract]   [Full Text] [Related]  

  • 17. I-131 MIBG detection of metastatic hepatic carcinoid.
    Kipper MS; Krohn L; Grossman PD
    Clin Nucl Med; 1994 Aug; 19(8):751. PubMed ID: 7955766
    [No Abstract]   [Full Text] [Related]  

  • 18. Reticulo-endothelial and blood-pool scanning in the diagnosis and differentiation of space occupying lesions of the liver.
    Andrews JT; Steven LW; Arkles LB; Sephton RG; Martin JJ
    Aust N Z J Surg; 1973 Jul; 43(1):14-8. PubMed ID: 4517793
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours.
    Nilsson O; Kölby L; Wängberg B; Wigander A; Billig H; William-Olsson L; Fjälling M; Forssell-Aronsson E; Ahlman H
    Br J Cancer; 1998 Feb; 77(4):632-7. PubMed ID: 9484822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic carcinoid tumor imaged with CT and a radiolabeled somatostatin analog: a case report.
    Lobrano MB; McCarthy K; Adams L; Neitzschman H
    Am J Gastroenterol; 1997 Mar; 92(3):513-5. PubMed ID: 9068482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.